ARCHIVES

Scientists Defend NCI, Criticize Post Series As Inaccurate

This article is from The Cancer Letter archive.

Vol. 07 No. 47 | November 20, 1981

Download PDF Visit The Full Archive

Related Articles

NC-Approved Clinical Trials

June 27, 2003

Switching to Tasigna After Gleevec Therapy Can Achieve Deeper Molecular Response

December 28, 2012

Bills Would Give FDA Authority to Approve Generic Biotech Drugs.

February 16, 2007

Wilding named director, Univ. of Wisconsin Cancer Center.

January 30, 2004

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

November 1, 1985

Lung Cancer Prevention Diet Study Concept Tabled By DCPC Board

February 8, 1985